Meningioma Mommas only funds meningioma specific research and is proud to kick off 2017 by fully funding Harvard University and Massachusetts General Hospital researchers, Dr. Robert Martuza and Dr. Hiroaki Wakimoto, with a $25,048 grant to launch their project, “Anti-angiogenic Oncolytic Virus Therapy for Meningioma.” This is exciting as there is no effective modality for…
DetailsDr. Nader Sanai, an Associate Professor of Neurological Surgery at the Barrow Neurological Institute in Phoenix, Arizona, has received a $15,000 grant to fund his latest research project, “A Phase 0/II Study of LEE011 in Recurrent Atypical and Malignant Meningioma Patients.” This proposal represents the first Phase 0 atypical and malignant meningioma trial in history. Dr. Sanai and…
DetailsMeningioma Mommas funded Dr. Garni Barkhoudarian and Dr. Daniel Kelly (John Wayne Cancer Institute at Saint John’s Health Center) with a $15,000 grant in December, 2013. Dr. Barkhoudarian writes, “This pilot study which resulted in the identification of numerous potential biomarkers between grade 2 and grade 3 meningiomas. Though this was primarily a feasibility study,…
DetailsMeningioma Mommas is thrilled to announce that Dr. Albert Kim has been awarded $20,952 to fully fund his latest research project, “Mechanisms of Radiation Resistance in Brain Meningiomas”. Dr. Kim, an academic neurosurgeon at Washington University in St. Louis studies meningiomas clinically and has been focusing on the effects of radiation therapy in aggressive grade II…
DetailsTwo years ago, Dr. Damon Reed approached Meningioma Mommas and asked if he could develop a survey regarding meningiomas and the effects they have with a focus on women with meningiomas deciding whether or not to have children. We are thrilled to share the following press release received today as well as the link to the…
DetailsDr. Long-Sheng Chang’s research is officially underway. Meningioma Mommas donated $10,000 to fund his project, “Evaluation of Novel Targeted Therapies for Both NF2-Associated and Sporadic Meningiomas.” The ultimate goal for Dr. Chang and his team at Ohio State University is to develop a medical therapy that effectively eradicates both NF2-associated and sporadic meningiomas. Meningioma Mommas…
Details“From the bottom of my heart, I sincerely thank Meningioma Mommas for supporting our research. In a time when research funding is so competitive, any penny counts! “Fearless” is the spirit that I have learned from patients with meningiomas like you. Despite how many tumors and surgeries you have and how life-altering the effects of these…
Details
